Image-guided therapy
Peripheral arterial interventions
Enhancing efficiency and bringing greater standardization to procedures for peripheral artery disease
The Philips vascular suite provides dedicated interventional tools and advanced vascular devices to support high levels of standardization and redefine outcomes for your peripheral artery disease (PAD) patients. Our Azurion platform allows you to seamlessly integrate all of your advanced imaging technologies, including IVUS and SmartCT, to support efficiency and clinical confidence. Our workflow and imaging applications are complimented by specialized treatment devices that provide the full suite of tools as you decide, guide, treat and confirm treatment results.
Confidence and consistency in interventions for peripheral artery disease
- Workflow: Philips Azurion Image Guided Therapy System offers workflow innovations designed to help vascular teams work efficiently.
- Imaging: The Philips imaging portfolio includes our SmartCT Roadmap for accurate and dynamic 3D guidance of guidewires and catheters. IVUS gives you a 360-degree view of the vessel to gain deeper insights to inform treatment decisions.
- Devices: Philips' devices portfolio includes crossing devices, vessel prep and definitive treatments for personalized PAD patient care.
Our purpose-built portfolio allows you to see clearly and treat optimally.
- Our portfolio of PAD solutions is designed to streamline your workflow from imaging to treatment and beyond. Azurion offers a clutter-free, comfortable lab environment with a streamlined workflow and industry-leading image quality.
- Our SmartCT Roadmap and IVUS imaging platforms seamlessly integrate into our Azurion system to provide advanced, dynamic imaging throughout the procedure.
- The specialized treatment portfolio for PAD is curated around the information that our imaging portfolio provides to ensure optimal care.
Insightful planning, guidance and treatment for peripheral disease procedures
- Azurion 7 M20 monoplane ceiling-mounted with FlexArm option provides unlimited imaging flexibility and exceptional positioning freedom.
- SmartCT Roadmap offers accurate and dynamic 3D guidance with a full 3D view with reduced X-ray dose and contrast medium usage.
- Philips market-leading IVUS is the only plug-and-play, phased array digital IVUS platform available in multiple sizes and platforms.
- Our diverse treatment portfolio has several Philips-only solutions to tackle even the most difficult disease presentation.
The use of Philips technology was essential, so as a provider, as a physician, to be able to have such an impact is absolutely unique and spectacular.
Abdul R. Halabi, MD
Interventional Cardiologist, Cardiology & Vascular Associates
Bloomfield Hills, Michigan, USA
Related procedures
Discover Philips solutions for aortic disease interventions to support each step of a procedure, improving efficiency and helping redefine outcomes.
Philips’ portfolio includes advanced imaging and specialized treatment solutions for even the most difficult deep venous procedures.
Discover Philips solutions for prostate artery embolization (PAE) to support confident planning and treatment decisions with minimal X-ray dose.
Footnotes
- Data shown is an average, based on the comparison between remotely connected and non-remotely connected systems. Data sample from 2018 for Allura FD and Azurion systems (n=9955).
- Kashyap VS. Pavkov ML, Bishop PD, et al. Angiography underestimates peripheral atherosclerosis: lumenographyrevisited. J Endovasc Ther. 2008;15(1): 117-125
- Internal sales data
- Dippel EJ, Makam P, Kovach R, et al. Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: initial results from the EXCITE ISR trial (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis). JACC Cardiovasc Interv. 2015;8(1 Pt A):92-101
- Gagne PJ, Tahara RW, Fastabend CP, et al. Venography versus intravascular ultrasound for diagnosing and treating iliofemoral vein obstruction. J Vasc Surg Venous Lymphat Disord. 2017;5(5):678-687. doi:10.1016/j.jvsv.2017.04.007
- Allan R, Puckridge P, Spark J, et al. The Impact of Intravascular Ultrasound on Femoropopliteal Artery Endovascular Interventions. J Am Coll Cardiol Intv. 2022 Mar, 15 (5) 536–546. www.doi.org/10.1016/j.jcin.2022.01.001
Disclaimer
Results are specific to the institution where they were obtained and may not reflect the results achievable at other institutions. Results in other cases may vary.